| Validating the anti-lymphoma pharmacodynamic actions of the endocannabinoids on canine non-Hodgkin lymphoma S Omer, S Pathak, R Nadar, D Bowen, M Sandey, M Dhanasekaran, ... Life Sciences 327, 121862, 2023 | 4 | 2023 |
| Effects of Cannabidiol,∆ 9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines S Omer, S Pathak, M Mansour, R Nadar, D Bowen, M Dhanasekaran, ... Biomolecules 14 (4), 495, 2024 | 3 | 2024 |
| Abstract PO-047: Anti-proliferative effect of cannabidiol (CBD) against B and T-cell lymphoma S Omer, D Boothe, M Mansour, M Dhanasekaran, S Pondugula Cancer Research 80 (21_Supplement), PO-047-PO-047, 2020 | 2 | 2020 |
| Anti-proliferative effect of cannabidiol (CBD) against B and T-cell lymphoma. S Omer, D Boothe, M Mansour, M Dhanasekaran, S Pondugula CANCER RESEARCH 80 (21), 2020 | 1 | 2020 |
| Anti-Cancer Effects of Endocannabinoids in Canine Non-Hodgkin Lymphoma S Omer Technological Advances in Science, Medicine and Engineering Conference 2021, 2021 | | 2021 |
| Cannabinoid: A Potential Anti-Cancer Agent for Non-Hodgkin Lymphoma S Omer Auburn University, 2021 | | 2021 |
| Abstract PO-28: Antitumor effects of cannabinoids against B-cell lymphoma S Omer, D Boothe, M Mansour, M Dhanasekaran, S Pondugula Blood Cancer Discovery 1 (3_Supplement), PO-28-PO-28, 2020 | | 2020 |
